The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia.
Diana Z PaderinaAnastasiia S BoikoIvan V PozhidaevIrina A MednovaAnastasiia A GoncharovaAnna V BocharovaOlga Yu FedorenkoElena G KornetovaArkadiy V SemkeNikolay A BokhanAnton J M LoonenSvetlana A IvanovaPublished in: Genes (2022)
Our results show that the DRD2 gene may be involved in the pathogenesis of metabolic disorders in patients with schizophrenia. Further analysis of possible genetic markers will allow for personalized treatment with minimal side effects and optimal efficacy. This which seems relevant in light of the recent focus on improving the quality of life and ensuring a high level of social adaptation of patients with schizophrenia.